Contrast-enhanced 3D black-blood magnetic resonance imaging for diagnosis of cerebral venous thrombosis
1
Issued Date
2024-01-01
Resource Type
ISSN
19714009
eISSN
23851996
Scopus ID
2-s2.0-85195609177
Journal Title
Neuroradiology Journal
Rights Holder(s)
SCOPUS
Bibliographic Citation
Neuroradiology Journal (2024)
Suggested Citation
Tunlayadechanont P., Chobaroon A., Chansakul T. Contrast-enhanced 3D black-blood magnetic resonance imaging for diagnosis of cerebral venous thrombosis. Neuroradiology Journal (2024). doi:10.1177/19714009241260798 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/98803
Title
Contrast-enhanced 3D black-blood magnetic resonance imaging for diagnosis of cerebral venous thrombosis
Author(s)
Author's Affiliation
Corresponding Author(s)
Other Contributor(s)
Abstract
Purpose: Cerebral venous thrombosis (CVT) is often under-recognized on routine magnetic resonance imaging (MRI) examinations without concomitant magnetic resonance venography (MRV). Contrast-enhanced black-blood MRI (BBMRI) based on a three-dimensional T1-weighted variable-flip-angle turbo spin echo sequence, one of the sequences used routinely in our practice, has the potential for detection of thrombi in patients with CVT. The aim of this study is to evaluate the diagnostic performance and enhancement patterns of contrast-enhanced three-dimensional BBMRI for the diagnosis of CVT. Materials and methods: Contrast-enhanced BBMRI and contrast-enhanced MRV sequences of 64 patients, acquired from June 2018 to January 2021, were retrospectively reviewed by neuroradiologists for detection of CVT in each venous sinus segment. Diagnostic performance values were calculated for contrast-enhanced BBMRI based on enhancement patterns. Results: Of 749 venous segments from 64 patients analyzed, CVT was demonstrated in 41 venous segments from 12 patients on contrast-enhanced MRV (CE MRV). Thick wall enhancement and total enhancement patterns were dominantly demonstrated in thrombosed segments. Compared with contrast-enhanced MRV, contrast-enhanced BBMRI had a patient-based sensitivity and specificity of 100% and 98.1%, respectively, and a segment-based sensitivity and specificity of 87.8% and 96.2%, respectively. The positive predictive value of contrast-enhanced BBMRI in detecting CVT was 92.3% (patient-based) and 57.1% (segment-based), and the negative predictive value was 100% (patient-based) and 99.3% (segment-based). Conclusion: Contrast-enhanced BBMRI has high diagnostic performance in detection and diagnosis of CVT. This sequence may be useful to recognize CVT when dedicated CE MRV was not performed in patients with nonspecific neurological symptoms.